These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7499217)

  • 1. Fluorescence resonance energy transfer reveals interleukin (IL)-1-dependent aggregation of IL-1 type I receptors that correlates with receptor activation.
    Guo C; Dower SK; Holowka D; Baird B
    J Biol Chem; 1995 Nov; 270(46):27562-8. PubMed ID: 7499217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 (IL-1) causes changes in lateral and rotational mobilities of IL-1 type I receptors.
    Guo C; Georgiadis KE; Dower SK; Holowka D; Baird BA
    Biochemistry; 1999 Feb; 38(5):1618-25. PubMed ID: 9931029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study.
    Damjanovich S; Bene L; Matkó J; Alileche A; Goldman CK; Sharrow S; Waldmann TA
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13134-9. PubMed ID: 9371812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation.
    Gadella TW; Jovin TM
    J Cell Biol; 1995 Jun; 129(6):1543-58. PubMed ID: 7790353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer.
    Broudy VC; Lin NL; Bühring HJ; Komatsu N; Kavanagh TJ
    Blood; 1998 Feb; 91(3):898-906. PubMed ID: 9446650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational dynamics and kinetics of peptide antagonist interactions with interleukin-1 receptor. Fluorescence studies using the NBD-labelled peptide AF12415.
    Cowley DJ; Schulze AJ
    J Pept Res; 1997 May; 49(5):444-54. PubMed ID: 9211226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta.
    Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP
    J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1.
    Curtis BM; Gallis B; Overell RW; McMahan CJ; DeRoos P; Ireland R; Eisenman J; Dower SK; Sims JE
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3045-9. PubMed ID: 2470087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-1 activity by soluble IL-1 receptors.
    Kurrle R; Lauffer L; Röder J; Kanzy EJ; Enssle KH; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):45-57. PubMed ID: 7575352
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural mapping of membrane-bound immunoglobulin E-receptor complexes: use of monoclonal anti-IgE antibodies to probe the conformation of receptor-bound IgE.
    Holowka D; Conrad DH; Baird B
    Biochemistry; 1985 Oct; 24(22):6260-7. PubMed ID: 2935182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence resonance energy transfer (FRET) and competing processes in donor-acceptor substituted DNA strands: a comparative study of ensemble and single-molecule data.
    Dietrich A; Buschmann V; Müller C; Sauer M
    J Biotechnol; 2002 Jan; 82(3):211-31. PubMed ID: 11999691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of epidermal growth factor (EGF) receptor aggregation in plasma membranes by fluorescence resonance energy transfer. Correlation of receptor activation with aggregation.
    Carraway KL; Koland JG; Cerione RA
    J Biol Chem; 1989 May; 264(15):8699-707. PubMed ID: 2498317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric measurement of fluorescence (Förster) resonance energy transfer from cyan fluorescent protein to yellow fluorescent protein using single-laser excitation at 458 nm.
    He L; Bradrick TD; Karpova TS; Wu X; Fox MH; Fischer R; McNally JG; Knutson JR; Grammer AC; Lipsky PE
    Cytometry A; 2003 May; 53(1):39-54. PubMed ID: 12701131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of type I Fc epsilon-receptors on the surface of mast cells probed by fluorescence resonance energy transfer.
    Kubitscheck U; Schweitzer-Stenner R; Arndt-Jovin DJ; Jovin TM; Pecht I
    Biophys J; 1993 Jan; 64(1):110-20. PubMed ID: 8431535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation.
    Nechansky A; Robertson MW; Albrecht BA; Apgar JR; Kricek F
    J Immunol; 2001 May; 166(10):5979-90. PubMed ID: 11342613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.
    Ju G; Labriola-Tompkins E; Campen CA; Benjamin WR; Karas J; Plocinski J; Biondi D; Kaffka KL; Kilian PL; Eisenberg SP
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2658-62. PubMed ID: 1826365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties.
    Budd DC; McDonald J; Emsley N; Cain K; Tobin AB
    J Biol Chem; 2003 May; 278(21):19565-73. PubMed ID: 12649280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.